Brexpiprazole open-label extension study for patients with MDD

• Research type

  Research Study

• Full title

  Interventional, open-label, long-term extension study to evaluate the safety and tolerability of brexpiprazole as adjunctive treatment in patients with major depressive disorder.

• IRAS ID

  133118

• Sponsor organisation

  H. Lundbeck A/S

• Eudract number

  2012-004169-42

• REC name

  North West - Greater Manchester South Research Ethics Committee

• REC reference

  13/NW/0600

• Date of REC Opinion

  29 Oct 2013

• REC opinion

  Further Information Favourable Opinion